Clinical Outcomes of Piperacillin/Tazobactam Treatment in Outpatient Parenteral Antimicrobial Therapy (OPAT) Programs: Comparison of Two Models of Opat Care

<b>Objectives</b>: Piperacillin/tazobactam (P/T) is a broad-spectrum β-lactam antibiotic frequently used in outpatient parenteral antimicrobial therapy programs (OPAT). We aim to compare the clinical outcomes of P/T treatment in two models of OPAT care in order to maximize the utilization of health...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Santiago J. Lora-Escobar, Laura Herrera-Hidalgo, Nerea Castillo-Fernández, Zaira R. Palacios-Baena, Rafael Luque-Márquez, Arístides De Alarcón, Ana Belén Guisado-Gil, Belén Gutierrez-Gutierrez, María Dolores Navarro-Amuedo, Julia Praena-Segovia, Marta Mejías Trueba, Juan Manuel Carmona-Caballero, José Manuel Sánchez Oliva, María Victoria Gil-Navarro, Luis E. López-Cortés
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2025-11-01
coleção:	Pharmaceutics
Assuntos:	piperacillin/tazobactam OPAT drug delivery
Acesso em linha:	https://www.mdpi.com/1999-4923/17/11/1429
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!